ConductScience.org, home
SCC-9
API referenceFor AI assistants

Cell line · CVCL_1685

Papers63

1 to 20 of 63

Download this page as JSON
PaperJournalYearHow we knowRetractedSource
Capsaicin suppresses metastasis in tongue squamous cell carcinoma by reversing epithelial-mesenchymal transition via the AMPK/HIF-1α/Claudin-1 axisBiol Direct2026Its Methods give the RRID and name the linePubMed
Dual targeting of ACSS2 and ACLY by a novel inhibitor S8588 suppresses oncogenic lipogenesis and overcomes metabolic compensation in oral squamous cell carcinoma.Int J Oral Sci2026Its Methods give the RRID and name the linePubMed
Genome-wide CRISPR screen identifies AMBRA1 as a potential biomarker of response to platinum-based therapies in oral squamous cell carcinomas.iScience2026Its Methods give the RRID and name the linePubMed
Newly identified invasion drivers define the tumor front in oral squamous cell carcinoma.Cell Death Discov2026Its Methods give the RRID and name the linePubMed
Maackia amurensis seed lectin inhibits oral squamous cell carcinoma tumorigenesis by suppressing N6-methyladenosine modification-mediated SRY-box transcription factor 2 expression.J Int Med Res2026Its Methods give the RRID and name the linePubMed
Isoform-specific cofactor recruitment through the intrinsically disordered N-terminus of p63 underlies differential transcriptional activities.bioRxiv2026Its Methods give the RRID and name the linePubMed
TNFRSF10B, a Therapeutic Target for Oral Squamous Cell Carcinoma Through Integrated Bioinformatics and Preliminary Experiments.Technol Cancer Res Treat2026Its Methods give the RRID and name the linePubMed
pH/ROS-Responsive Injectable Hydrogel Co-Loaded with B7-H3 Blocker and NETs Suppressor Boosts OSCC Synergistic Immunotherapy.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Interplay of YEATS2 and GCDH regulates histone crotonylation and drives EMT in head and neck cancer.Elife2025Its Methods give the RRID and name the linePubMed
Blocking YAP1-Liprin-β2 interaction impedes metastasis and promotes tumor suppression in head and neck squamous carcinoma.Sci Rep2025Its Methods give the RRID and name the linePubMed
Elucidating the role of N-myristoylation in the excessive membrane localization of PD-L1 in hypoxic cancers and developing a novel NMT1 inhibitor for combination with immune checkpoint blockade therapy.
J Exp Clin Cancer Res2025Its Methods give the RRID and name the linePubMed
Tongue squamous cell carcinoma-derived exosomes miR-21-5p affect tumor progression via promoting M2 macrophage polarization.Noncoding RNA Res2025Its Methods give the RRID and name the linePubMed
EGFRvIII-driven microenvironmental fibroblast activation and transformation accelerate oral cancer progression via lipocalin-2/STAT3 axis.Neoplasia2025Its Methods give the RRID and name the linePubMed
The PTTG1/VASP axis promotes oral squamous cell carcinoma metastasis by modulating focal adhesion and actin filaments.Mol Oncol2025Its Methods give the RRID and name the linePubMed
TNO155 is a selective SHP2 inhibitor to target PTPN11-dependent oral squamous cell carcinoma.Heliyon2024Its Methods give the RRID and name the linePubMed
High TNF and NF-κB Pathway Dependency Are Associated with AZD5582 Sensitivity in OSCC via CASP8-Dependent Apoptosis.Cancer Res Commun2024Its Methods give the RRID and name the linePubMed
Capsaicin exerts synergistic pro-apoptotic effects with cisplatin in TSCC through the calpain pathway via TRPV1.J Cancer2024Its Methods give the RRID and name the linePubMed
The immunomodulatory ballet of tumour-derived extracellular vesicles and neutrophils orchestrating the dynamic CD73/PD-L1 pathway in cancer.J Extracell Vesicles2024Its Methods give the RRID and name the linePubMed
Subcellular localization of PD-L1 and cell-cycle-dependent expression of nuclear PD-L1 variants: implications for head and neck cancer cell functions and therapeutic efficacy.Mol Oncol2024Its Methods give the RRID and name the linePubMed
ORAOV1, CCND1, and MIR548K Are the Driver Oncogenes of the 11q13 Amplicon in Squamous Cell Carcinoma.Mol Cancer Res2024Its Methods give the RRID and name the linePubMed

cell-lines-2026-11-14-0.1.0

Next page

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_1685/papers

API referenceFor AI assistants